MMP9 and colonic neoplasm: These observations were further corroborated by additional ChIPac experiments in which exposure of SW620 colon cancer cells to MMP‐9 inhibitor MMP9‐I still allowed MMP‐9 occupancy but almost completely crippled H3NT proteolysis at target genes (Fig. 5D).